541 related articles for article (PubMed ID: 15362740)
1. The value of p53 protein expression in gallbladder carcinoma: analysis of 60 cases.
da Rocha AO; Coutinho LM; Scholl JG; Leboutte LD
Hepatogastroenterology; 2004; 51(59):1310-4. PubMed ID: 15362740
[TBL] [Abstract][Full Text] [Related]
2. Expression of the GLUT1 glucose transporter in gallbladder carcinomas.
Kim YW; Park YK; Yoon TY; Lee SM
Hepatogastroenterology; 2002; 49(46):907-11. PubMed ID: 12143238
[TBL] [Abstract][Full Text] [Related]
3. Genetic alterations involved in the development of gallbladder carcinomas from Greek patients.
Saetta A; Lazaris AC; Michalopoulos NV; Davaris PS
Hepatogastroenterology; 2001; 48(41):1284-8. PubMed ID: 11677947
[TBL] [Abstract][Full Text] [Related]
4. DNA ploidy pattern and tumor suppressor gene p53 expression in gallbladder carcinoma.
Roa I; Villaseca M; Araya JC; Roa J; de Aretxabala X; Fuentealba P; Melo A
Cancer Epidemiol Biomarkers Prev; 1997 Jul; 6(7):547-50. PubMed ID: 9232344
[TBL] [Abstract][Full Text] [Related]
5. p53 protein expression and prognosis in gallbladder carcinoma and premalignant lesions.
Ajiki T; Onoyama H; Yamamoto M; Asaka K; Fujimori T; Maeda S; Saitoh Y
Hepatogastroenterology; 1996; 43(9):521-6. PubMed ID: 8799388
[TBL] [Abstract][Full Text] [Related]
6. [Expression of p53 in gallbladder carcinoma and in dysplastic and metaplastic lesions of the surrounding mucosa].
Billo P; Marchegiani C; Capella C; Sessa F
Pathologica; 2000 Aug; 92(4):249-56. PubMed ID: 11029885
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of BAT-26 as an indicator of microsatellite instability in gallbladder carcinomas.
Saetta A; Koilakou SV; Michalopoulos NV; Davaris PS
Hepatogastroenterology; 2003; 50(54):1799-802. PubMed ID: 14696408
[TBL] [Abstract][Full Text] [Related]
8. Heparanase expression in gallbladder carcinoma and its correlation to prognosis.
Wu W; Pan C; Yu H; Gong H; Wang Y
J Gastroenterol Hepatol; 2008 Mar; 23(3):491-7. PubMed ID: 17524042
[TBL] [Abstract][Full Text] [Related]
9. High frequency of p53 gene mutation in adenocarcinomas of the gallbladder.
Fujii K; Yokozaki H; Yasui W; Kuniyasu H; Hirata M; Kajiyama G; Tahara E
Cancer Epidemiol Biomarkers Prev; 1996 Jun; 5(6):461-6. PubMed ID: 8781743
[TBL] [Abstract][Full Text] [Related]
10. Genetic analysis of xanthogranulomatous cholecystitis: precancerous lesion of gallbladder cancer?
Takada M; Horita Y; Okuda S; Okumoto S; Samizo M; Wada T; Kuroda Y; Maeda S
Hepatogastroenterology; 2002; 49(46):935-7. PubMed ID: 12143246
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of aggressive treatment of stage IV gallbladder cancer and predictors of survival.
Todoroki T; Takahashi H; Koike N; Kawamoto T; Kondo T; Yoshida S; Kashiwagi H; Otsuka M; Fukao K; Saida Y
Hepatogastroenterology; 1999; 46(28):2114-21. PubMed ID: 10521952
[TBL] [Abstract][Full Text] [Related]
12. Gallbladder cancer in a high risk area: morphological features and spread patterns.
Roa I; Araya JC; Villaseca M; Roa J; de Aretxabala X; Ibacache G
Hepatogastroenterology; 1999; 46(27):1540-6. PubMed ID: 10430291
[TBL] [Abstract][Full Text] [Related]
13. [p53 and p27 gene expression in subserosal gallbladder carcinoma].
Roa E I; Lantadilla H S; Ibacache S G; de Aretxabala U X
Rev Med Chil; 2009 Aug; 137(8):1017-22. PubMed ID: 19915764
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of N-myristoyltransferase in gallbladder carcinomas.
Rajala RV; Radhi JM; Kakkar R; Datla RS; Sharma RK
Cancer; 2000 May; 88(9):1992-9. PubMed ID: 10813869
[TBL] [Abstract][Full Text] [Related]
15. Adenosquamous/squamous cell carcinoma of the gallbladder.
Chan KM; Yu MC; Lee WC; Jan YY; Chen MF
J Surg Oncol; 2007 Feb; 95(2):129-34. PubMed ID: 17262729
[TBL] [Abstract][Full Text] [Related]
16. Microsatellite instability in preneoplastic and neoplastic lesions of the gallbladder.
Roa JC; Roa I; Correa P; Vo Q; Araya JC; Villaseca M; Guzmán P; Schneider BG
J Gastroenterol; 2005 Jan; 40(1):79-86. PubMed ID: 15692793
[TBL] [Abstract][Full Text] [Related]
17. Hyalinizing cholecystitis and associated carcinomas: clinicopathologic analysis of a distinctive variant of cholecystitis with porcelain-like features and accompanying diagnostically challenging carcinomas.
Patel S; Roa JC; Tapia O; Dursun N; Bagci P; Basturk O; Cakir A; Losada H; Sarmiento J; Adsay V
Am J Surg Pathol; 2011 Aug; 35(8):1104-13. PubMed ID: 21716080
[TBL] [Abstract][Full Text] [Related]
18. Reduced expression of Raf-1 kinase inhibitory protein is a significant prognostic marker in patients with gallbladder carcinoma.
Kim HS; Kim GY; Lim SJ; Park YK; Kim YW
Hum Pathol; 2010 Nov; 41(11):1609-16. PubMed ID: 20688353
[TBL] [Abstract][Full Text] [Related]
19. [Gallbladder carcinoma. Our experience].
Gentilli S; Fronticelli CM; Ferrero A; Quiriconi F; Corradino R
Minerva Chir; 1996 Apr; 51(4):183-6. PubMed ID: 8927266
[TBL] [Abstract][Full Text] [Related]
20. Sporadic TP53 transition mutations in chronic cholecystitis are possibly linked to gallbladder carcinogenesis.
Yanagisawa N; Yamashita K; Kuba T; Okayasu I
Anticancer Res; 2010 Nov; 30(11):4443-9. PubMed ID: 21115891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]